These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bcl-2 over-expression and activation of protein kinase C suppress the trail-induced apoptosis in Jurkat T cells. Guo BC, Xu YH. Cell Res; 2001 Jun; 11(2):101-6. PubMed ID: 11453541 [Abstract] [Full Text] [Related]
3. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
4. [Expression of TRAIL(114-281) mediated by adeno-associated virus and its tumoricidal activity]. Ma H, Liu YX, Liu SL, Xu RA, Zheng DX. Zhonghua Yi Xue Za Zhi; 2004 Oct 02; 84(19):1635-41. PubMed ID: 15569460 [Abstract] [Full Text] [Related]
5. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Singh TR, Shankar S, Chen X, Asim M, Srivastava RK. Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373 [Abstract] [Full Text] [Related]
6. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T. Int J Mol Med; 2006 Jul 01; 18(1):41-7. PubMed ID: 16786154 [Abstract] [Full Text] [Related]
7. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW. Cancer Res; 2004 Jun 15; 64(12):4078-81. PubMed ID: 15205314 [Abstract] [Full Text] [Related]
8. Adenoviral gene transfer of tumor necrosis factor-related apoptosis-inducing ligand overcomes an impaired response of hepatoma cells but causes severe apoptosis in primary human hepatocytes. Armeanu S, Lauer UM, Smirnow I, Schenk M, Weiss TS, Gregor M, Bitzer M. Cancer Res; 2003 May 15; 63(10):2369-72. PubMed ID: 12750253 [Abstract] [Full Text] [Related]
9. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K. Oncogene; 2003 Mar 20; 22(11):1653-62. PubMed ID: 12642868 [Abstract] [Full Text] [Related]
10. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M. Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621 [Abstract] [Full Text] [Related]
11. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Shankar S, Singh TR, Srivastava RK. Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092 [Abstract] [Full Text] [Related]
12. [Synergistic effect of tumor necrosis factor-related apoptosis inducing ligand (TRAIL) and doxorubicin on human colon cancer SW480 cells]. Xu LH, Deng CS, Zhu YQ, Liu SQ. Ai Zheng; 2003 Aug 15; 22(8):816-20. PubMed ID: 12917026 [Abstract] [Full Text] [Related]
13. 8-Chloro-adenosine sensitizes a human hepatoma cell line to TRAIL-induced apoptosis by caspase-dependent and -independent pathways. Wang M, Liu Y, Liu S, Zheng D. Oncol Rep; 2004 Jul 15; 12(1):193-9. PubMed ID: 15201983 [Abstract] [Full Text] [Related]
14. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Nakamoto N, Higuchi H, Kanamori H, Kurita S, Tada S, Takaishi H, Toda K, Yamada T, Kumagai N, Saito H, Hibi T. Int J Oncol; 2006 Sep 15; 29(3):625-35. PubMed ID: 16865278 [Abstract] [Full Text] [Related]
15. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. Bai J, Sui J, Demirjian A, Vollmer CM, Marasco W, Callery MP. Cancer Res; 2005 Mar 15; 65(6):2344-52. PubMed ID: 15781649 [Abstract] [Full Text] [Related]
16. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations. Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT. Clin Cancer Res; 2005 Apr 15; 11(8):3075-83. PubMed ID: 15837763 [Abstract] [Full Text] [Related]
17. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma. Shiraki K, Yamanaka T, Inoue H, Kawakita T, Enokimura N, Okano H, Sugimoto K, Murata K, Nakano T. Int J Oncol; 2005 May 15; 26(5):1273-81. PubMed ID: 15809718 [Abstract] [Full Text] [Related]
18. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
19. Expression and antitumor effects of TRAIL in human cholangiocarcinoma. Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands JR. Hepatology; 2000 Sep 01; 32(3):523-7. PubMed ID: 10960444 [Abstract] [Full Text] [Related]
20. Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis. Kim JY, Kim YH, Chang I, Kim S, Pak YK, Oh BH, Yagita H, Jung YK, Oh YJ, Lee MS. Oncogene; 2002 May 09; 21(20):3139-48. PubMed ID: 12082629 [Abstract] [Full Text] [Related] Page: [Next] [New Search]